CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-05-11 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2011-05-11 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Warrant | +40,169 | 40,169 | ||
| 2011-05-11 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Warrant | +17,857 | 17,857 | ||
| 2011-05-09 | JONES STEPHANIE PRESIDENT | Sale | −4,982,103 | 17,897 |
Page 28 of 28 · 544 trades